Physician profile
Walter R Cazayoux
NPI 1073634861
$3,756.11
in general payments reported to CMS, 2019-2025
19 companies · $483 in 2025
The $483 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $452 · 2020: $210 · 2021: $235 · 2022: $1,294 · 2023: $719 · 2024: $364 · 2025: $483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,565.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,535.05 | 2022-2025 | Urolift, Barrigel |
| Cook Medical LLC | $339.49 | 2019-2024 | Litho 150 |
| Procept Biorobotics Corporation | $257.58 | 2023-2025 | Aquabeam Robotic System |
| Medtronic, INC. | $221.51 | 2022-2024 | Interstim |
| Neotract INC. | $206.18 | 2019-2020 | |
| Kerecis Limited | $171.68 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Astellas Pharma US INC | $142.26 | 2019-2022 | |
| Pfizer INC. | $128.08 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $121.70 | 2023 | Gemtesa |
| Laborie Medical Technologies Corp. | $121.42 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Urogen Pharma, INC. | $106.31 | 2023-2025 | Jelmyto |
| Medtronic USA, INC. | $100.33 | 2019-2020 | |
| Boston Scientific Corporation | $93.38 | 2023 | Advance Xp |
| Axonics, INC. | $67.62 | 2022-2023 | Bulkamid |
| Myovant Sciences INC. | $62.62 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Ih INC. | $33.87 | 2019 | |
| Abc Home Medical Supply, INC. | $17.91 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.74 | 2019 | |
| Abbvie INC. | $14.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Cazayoux listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.